I would really like to thank Disease Models and Mechanisms journal for the Read & Publish agreement with my university that has allowed publication of my recent article in an efficient and timely way and that is free of charge for the authors. This facility is very useful for many researchers with limited funding, allowing Open Access publishing without financial penalty to authors. The Company of Biologists shows very progressive thinking in this regard.
I am delighted that the Hebrew University of Jerusalem has a Read & Publish agreement with The Company of Biologists for supporting Open Access publication. I published my first two first-author publications as a graduate student in Development, so now publishing again as a PI was an special moment in my career, that showcased the significance of this journal in our field.
I always try to publish Open Access. In this particular paper we reported a method that is widely relevant, which made the impact of the support for Open Access even greater!
I was so happy to publish this article in Development fee-free. It was a lifesaver for me because this project was supported by my institutional start-up funds, which expired last year. This Read & Publish agreement allowed us to get our work out there in the best way possible, as an Open Access publication, but without the major costs as is typical for some other journals. Also, I loved how quickly the publishing process was with Development.
I am delighted that the Stowers Institute has a Read & Publish agreement with The Company of Biologists because it ensured the research published in Development was freely and rapidly available to a wide audience. This was important to us, as our work on this project involved interdisciplinary approaches that are relevant for people in diverse fields. We wanted the scientific community to be aware of our findings and have free access to the information in a timely manner.
I am delighted that my institution has a Read & Publish agreement with The Company of Biologists. This meant that by choosing to send our team’s first manuscript to the fantastic journal Development, the submission process was straightforward, cost-free, and worry-free, and we benefitted from great editorial support – all of which are invaluable as a newly established group. This has led to a publication that everyone can access, which will hopefully amplify its impact. We look forward to publishing more Open Science with The Company of Biologists!
We are delighted to publish our paper in Disease Models and Mechanisms immediately Open Access under the Read & Publish agreement with University College London. This is an important agreement to allow for free Open Access to our articles, which will allow for immediate dissemination of our work.
I was thrilled to learn that our manuscript got accepted for publication in Journal of Cell Science. The icing on the cake was discovering it would be published fee-free Open Access! Thanks to the Read & Publish agreement with the University of Tübingen, our work became immediately accessible to a wide audience. This not only supports open science but also eases the publishing-associated financial burden, particularly relevant for early-career researchers and those with limited funding. Moreover, this initiative grants us unlimited read access to The Company of Biologists’ hybrid journals.
Yet another professional and pain free handling of our manuscript at Journal of Cell Science, and the Read & Publish agreement with University of Bristol meant it was fee-free for us to publish Open Access, allowing everyone to read our paper immediately.
Nice deal for readers and authors: Published Open Access without having to pay for it from my limited funding . Thanks to Cardiff University and The Company of Biologists.
It was great to discover that the University of Sussex library had signed a Read & Publish agreement with The Company of Biologists. It made publishing an article in Journal of Experimental Biology very straightforward. It’s important for labs like mine that have relatively little funding. It also supports open academia, ensuring anyone can read the work, which was important to me and the early-career researchers in my lab.